Member Info for nomlungu

This may be of interest to some - technology with a twist? Molecular genetics guide from Miami University:

http://fig.cox.miami.edu/~cmallery/150/gene/mol_gen.htm

Noise et al,

It is all about shapes and their interactions [IMO] - this Miami University link is a well of knowledge if you are prepared to engage and have some scientific understanding:

http://fig.cox.miami.edu/~cmallery/150/gene/mol_gen.htm

I believe maths will solve many of the problems [quantum annealing - Math's Prof question?] by engineering new drugs.

https://www.proteinqure.com/

But then again I am a blind deaf mute so evidently it must be remembered never to believe what is posted on a bulletin board.

The Market Makers have so many shares to sell - where are they getting them from. Are Link exiting - if so what price have the MMs agreed to take them at?

It seems to me like a game of pass the parcel when the unlucky final holders gets to stare into the face of a placing which they had convinced themselves would not happen [even though they have previously announced via RNS that fundraising was part of the loan deal that got muddied by TRX missing revenue targets].

But who cares, only one distressed seller to go.

ValJu,

I would use low frequency white noise - still cruel though.

? - Sell below Bid?

sells just over nominal value... whale trap?

SP keeps dropping and people keep posting a deep value hunter link - is this a duster?

have rampers run out of battlefield dressings or is the patient just bleeding out?

https://www.youtube.com/watch?v=H7FVTNcXsj0

https://youtu.be/x4Awi88HywU

PolyU is getting cleared and it might be messy...

https://edition.cnn.com/asia/live-news/hong-kong-protests-live-nov-18-intl-hnk/index.html

Interesting read:

https://www.quantamagazine.org/tuft-cells-that-taste-danger-set-off-immune-responses-20191115/

https://www.bloomberg.com/news/articles/2019-11-16/cannabis-flameout-rivals-dot-com-bust-as-legal-fears-curb-growth?srnd=premium-europe

Interesting read:

https://thehill.com/opinion/healthcare/470316-cancer-therapy-dispute-highlights-need-to-repeal-con-laws

COdey,

I have had a few bags out of this share in the past. I was quoted 0.465 when the first transaction was being hawked but was not tempted because IP Group and Link have yet to show their hands.

I posted this on the 0QLN board on the 25th of October:

'TRX - There may be another distressed seller as one of Invesco funds may be getting stressed having co-invested in some of the flops.'

It did drop...

Jarv55,

'There really is some rubbish posted on here.'

It is the point I was making. Most are riding a sentiment wave and have little understanding of the science or the medical applications being targeted.

https://www.darpa.mil/news-events/2019-02-06a

I have been running a model over TRX for since 2016 - there was a reason why the brokers were selling the shares cheaply earlier this week and the cash flow problems were widely known. I have asked some questions of the science and the only response was 'just trading'.

Many have bought Level 2 access but do not know about the black pools that drive the market swings - what happens when the other 2 'distressed' shareholders exit?

https://www.lseg.com/areas-expertise/our-markets/turquoise

Jeezz,

What do you people get wrong - if nobody sold and there are buyers the price just goes up. Who cares about the science, cash flow problems and the recapitalisation as it is all just fake news to scare you to sell whilst others buy your shares cheaply whilst the Market Makers eat Lobsters.

#sarcasm #recapitalisation #fake_news

langtro,

I made a model earlier this year that produced red flags. Both Boris and Jeremy want to bring in fibre broadband so any UK based medical centre will be able to outsource the scans to a poorer country [probably the Philippines but possibly Cuba as the time benefit from time zones could be a factor].

Torreaguas,

TRX have updated their rule 26 info about significant shareholders that shows a change that has yet to be announced by an RNS.

https://www.tissueregenix.com/investors/shareholder-centre/advisors-and-shareholders/